SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-093351
Filing Date
2024-08-08
Accepted
2024-08-08 08:05:23
Documents
54
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pepg-20240630.htm   iXBRL 10-Q 1997663
2 EX-10.1 pepg-ex10_1.htm EX-10.1 16655
3 EX-31.1 pepg-ex31_1.htm EX-31.1 18686
4 EX-31.2 pepg-ex31_2.htm EX-31.2 17676
5 EX-32.1 pepg-ex32_1.htm EX-32.1 7754
6 EX-32.2 pepg-ex32_2.htm EX-32.2 7785
  Complete submission text file 0000950170-24-093351.txt   6279347

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pepg-20240630.xsd EX-101.SCH 896374
56 EXTRACTED XBRL INSTANCE DOCUMENT pepg-20240630_htm.xml XML 721477
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41374 | Film No.: 241186161
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)